Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01056432 · ClinicalTrials.gov registry record
Bone UltraSonic Scanner (BUSS) Clinical Optimization Study
A clinical trial, sponsored by Artann Laboratories.
- Completed
- Registry status
- 100
- Enrollment target
NCT01056432: Completed study, sponsored by Artann Laboratories.
NCT01056432 is a clinical trial that has completed, run by Artann Laboratories. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01056432 has completed, sponsored by Artann Laboratories.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The aim of this clinical study using Bone UltraSonic Scanner (BUSS) is to obtain clinical data which will help to optimize the BUSS examination procedure and its diagnostic algorithms for assessment of bone conditions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-01 |
What the finished NCT01056432 record still lists
NCT01056432 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01056432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01056432 about?
NCT01056432 is a clinical study titled "Bone UltraSonic Scanner (BUSS) Clinical Optimization Study". The aim of this clinical study using Bone UltraSonic Scanner (BUSS) is to obtain clinical data which will help to optimize the BUSS examination procedure and its diagnostic algorithms for assessment of bone conditions.
What is the current status of trial NCT01056432?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2010-01. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT01056432?
This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia